These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17111781)

  • 1. The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians.
    Mannucci C; Douketis JD
    Intern Emerg Med; 2006; 1(2):96-104. PubMed ID: 17111781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Bridging" therapy in patients on long-term vitamin K antagonist treatment: a yet unsolved issue.
    Baudo F
    Intern Emerg Med; 2006; 1(2):94-5. PubMed ID: 17111780
    [No Abstract]   [Full Text] [Related]  

  • 3. Stroke prevention versus bleeding risk of vitamin-K antagonists: a double-edged sword in patients with atrial fibrillation who require surgery.
    Dobrev D; Goette A; Ravens U
    Cardiovasc Ther; 2009; 27(4):223-5. PubMed ID: 19903184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bridging anticoagulation].
    Schellong SM; Halbritter K; Haas S
    Chirurg; 2007 Feb; 78(2):125-6, 128-32. PubMed ID: 17252252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
    Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
    Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
    Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update in bridging anticoagulation.
    Kaatz S; Paje D
    J Thromb Thrombolysis; 2011 Apr; 31(3):259-64. PubMed ID: 21327504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Douketis JD; Berger PB; Dunn AS; Jaffer AK; Spyropoulos AC; Becker RC; Ansell J
    Chest; 2008 Jun; 133(6 Suppl):299S-339S. PubMed ID: 18574269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative management of antithrombotic therapy in cardiovascular patients.
    Nuttall MT; Rodgers GM
    Methodist Debakey Cardiovasc J; 2011; 7(4):10-4. PubMed ID: 22143470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy.
    Spyropoulos AC; Bauersachs RM; Omran H; Cohen M
    Curr Med Res Opin; 2006 Jun; 22(6):1109-22. PubMed ID: 16846544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation.
    Spyropoulos AC; Turpie AG
    Curr Opin Pulm Med; 2005 Sep; 11(5):373-9. PubMed ID: 16093808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perioperative heparin bridging is rarely indicated].
    Nielsen JD; Münster AM; Husted SE
    Ugeskr Laeger; 2016 Feb; 178(9):V12150952. PubMed ID: 26957485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Standardized Perioperative Management Protocol in the Adult Hematology Anticoagulation Management Service.
    Lum DJ; Ross PA; Bishop MA; Caetano ML; Malpani R; Streiff MB
    Ann Pharmacother; 2017 Dec; 51(12):1077-1083. PubMed ID: 28677422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
    Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
    J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Management in Patients Using Vitamin K Antagonists: Observational Cohort Study.
    Burggraaf JLI; van Rein N; van der Meer FJM; Lijfering WM
    Thromb Haemost; 2020 Mar; 120(3):495-504. PubMed ID: 31940676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
    Pritchard ER; Murillo JR; Putney D; Hobaugh EC
    J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perioperative control of vitamin K antagonists in elective surgery].
    Revigliono JI; Cornavaca T; Becerra F; Albertini R; Contreras AE; Tabares A
    Medicina (B Aires); 2014; 74(5):385-90. PubMed ID: 25347900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.